AI
Commented by Armin Schulz on June 17th, 2025 | 07:25 CEST
Pharmaceutical revolution 2025: Why Novo Nordisk, NetraMark Holdings, and Bayer are doubling their returns through AI efficiency
The pharmaceutical industry is undergoing a digital transformation in 2025. Artificial intelligence is decoding active ingredients in record time, big data is driving personalized therapies, and blockchain is securing supply chains. These technologies are catapulting efficiency skyward and dramatically reducing development costs in a billion-dollar market that is growing steadily due to demographic change. Those who identify the right companies now will benefit from the disruptive wave. Therefore, we look at three companies that could benefit from this change: Novo Nordisk, NetraMark Holdings, and Bayer.
Read
Commented by André Will-Laudien on June 13th, 2025 | 07:00 CEST
The three IT musketeers – AI, high tech, quantum computing! NetraMark Holdings, Bayer, Novo Nordisk, and D-Wave
A new edition of GTC 2025 is currently underway in the French capital, Paris, where NVIDIA CEO Jensen Huang spoke at length about the future of artificial intelligence. As usual, he also made some interesting comments about quantum computers. In the eyes of the NVIDIA CEO, quantum computer technology has reached a decisive turning point and will soon be able to solve some interesting problems that would take even NVIDIA's most advanced AI systems years of computing time to solve. The requirements go beyond pattern recognition, automation, and real-time decisions. Recently, AI has also been playing a significant role in medicine and pharmaceutical development. For some stocks, there is, therefore, a daily reason to reach new highs. Now is the time for investors to focus!
Read
Commented by Armin Schulz on June 12th, 2025 | 07:00 CEST
TUI, naoo, Palantir – Into a golden future with digitalization and AI
2025 will be a key year for companies that transform technological innovation into real customer value and thus offer investors exceptional returns in the long term. Three companies are setting standards here and making their businesses fit for the future. A travel giant is revolutionizing the vacation experience with digital platforms, a social commerce solution is driving local retail networks, and a data analyst is dominating Industry 4.0 with AI. Their growth strategies are not only redefining markets but also opening up concrete profit opportunities. Here is how you can leverage the tech transformation of TUI, naoo, and Palantir for your portfolio.
Read
Commented by André Will-Laudien on June 11th, 2025 | 07:10 CEST
Artificial intelligence predicts a perfect summer – 150% chance with Lufthansa, Credissential, TUI, and D-Wave
It is worth taking a closer look - even if many might blink in disbelief. Despite ongoing geopolitical tensions and a sluggish economy, the DAX 40 index has already surged by 20% in 2025. Investors are clearly no longer allowing themselves to be rattled by tariff threats and bleak headlines because no one wants to be without stocks anymore. Artificial intelligence is now even available as investment advice, which also recommends a healthy diversification across all asset classes, sectors, and countries around the world in order to generate at least 5% per annum. Yes, 5% - that is the ideal scenario for people who already have substantial capital. Risk-aware and even speculative investors would like to see a little more. Summer is approaching – typically a slow season – but AI is predicting temperatures in Germany at times exceeding 40 degrees Celsius. We take a look at stocks that are already in a hot phase.
Read
Commented by Stefan Feulner on June 10th, 2025 | 07:05 CEST
Palantir, NetraMark, Qualcomm – Caution, buy signals!
Artificial intelligence is fundamentally changing the economy. It optimizes processes, reduces costs, and creates new business models. Its use in the healthcare and pharmaceutical sectors is currently developing particularly dynamically. Data-based decisions and personalized medicine are significantly increasing efficiency. According to experts, the global market for AI in healthcare could grow disproportionately in the coming years. Many AI companies are still in the early stages of their development.
Read
Commented by Fabian Lorenz on June 3rd, 2025 | 07:20 CEST
A bombshell and a buying opportunity! BioNTech, Bayer, and AI stock NetraMark
Bombshell news from BioNTech. The Company has announced a collaboration for its cancer pipeline - billions in revenue are on the horizon. The stock has surged significantly. Are there other exciting buying opportunities in the biotech and pharma sectors right now? US politics have recently dampened industry sentiment. The Trump administration wants to lower drug prices. One potential beneficiary is NetraMark, as this AI gem helps industry cut development costs and timelines. In addition, takeover speculation could drive the stock in the second half of the year. And what is Bayer doing? The stock has outperformed the DAX in 2025. Are there reasons to consider buying?
Read
Commented by Nico Popp on June 3rd, 2025 | 07:00 CEST
Get more out of your money! Scaling is happening here: Apple, Credissential, and Shopify
For years, banks have controlled how we manage our money. The structures surrounding payment flows and investments are still quite rigid. But the old structures are breaking up and offering new potential - for digitally savvy users and investors alike. We show you what is happening in fintech and e-commerce and how investors can benefit.
Read
Commented by Stefan Feulner on June 2nd, 2025 | 07:00 CEST
Rheinmetall, Volatus Aerospace, C3.ai – Upgrades and explosive results
The quarterly reporting season is drawing to a close, with chip giant Nvidia being the last of the Magnificent 7 stocks to present its figures. Analysts' ambitious targets were once again smashed, but uncertainties surrounding the trade war between China and the US are dampening the outlook for the industry leader. In contrast, uncertainty about the geopolitical situation continues to boost business for defense companies, which are receiving ever-higher price targets from analysts.
Read
Commented by Nico Popp on May 29th, 2025 | 07:00 CEST
The next AI revolution is being spearheaded by these hidden champions: Palantir, NetraMark, Roche
Are you still working the same way you did five years ago? Let's be honest: AI has changed a lot. The opportunities are enormous, especially in biotechnology. Already in 2024, one in four venture capital dollars for AI projects went to the healthcare sector, according to Silicon Valley Bank. Although around 80% of the industry already works with AI, there is a wide range of applications, with significant differences between experiments and groundbreaking innovations. We present three AI beneficiaries from the healthcare sector and explain how investors can profit.
Read
Commented by Armin Schulz on May 28th, 2025 | 07:00 CEST
Volatus Aerospace – A key player in the booming drone market
Global conflicts are currently drawing attention to drone technology, yet its civilian potential is often underestimated. Whether in industry, logistics, or environmental projects, unmanned systems are fundamentally changing work processes. Volatus Aerospace, based in Canada, operates strategically as a dual-use provider, combining commercial and security applications. Following a comprehensive restructuring through 2024, the Company could emerge as a hidden champion in this billion-dollar market - driven by strategic partnerships and regulatory adjustments.
Read